Adicet Bio
ACET
49 hedge funds and large institutions have $128M invested in Adicet Bio in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
28% more capital invested
Capital invested by funds: $100M → $128M (+$27.8M)
20% more funds holding
Funds holding: 41 → 49 (+8)
0.1% more ownership
Funds ownership: 0.37% → 0.47% (+0.1%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$35M |
| 2 |
Jennison Associates
New York
|
+$5.91M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.92M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.84M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$299K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$198K |
| 3 |
Morgan Stanley
New York
|
-$162K |
| 4 |
JP Morgan Chase
New York
|
-$40.9K |
| 5 |
BlackRock
New York
|
-$17.3K |
ACET Hedge Fund Activity: Q1 2019 in Review
49 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2019, worth a combined $128M — up 28% from $100M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ACET positions and 3 closed out — a net gain of 8 holders — while 18 added to existing stakes and 7 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $35M. The largest seller was State Street, cutting an estimated $299K.
- 49 institutional investors held Adicet Bio (ACET) as of Q1 2019, up from 41 in Q4 2018.
- Funds reported $128M of Adicet Bio stock for Q1 2019, up 28% quarter-over-quarter.
- 11 funds opened new Adicet Bio positions in Q1 2019 and 3 closed out, a net change of +8 holders.
- The largest Adicet Bio buyer in Q1 2019 was OppenheimerFunds, an estimated $35M added.
- The largest Adicet Bio seller in Q1 2019 was State Street, an estimated $299K sold.
Based on aggregated 13F filings for Q1 2019.